Trial Profile
A Study of ABT-751 in Patients With Renal Cell Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2008
Price :
$35
*
At a glance
- Drugs ABT 751 (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 16 Sep 2005 New trial record.